254 related articles for article (PubMed ID: 28760618)
21. The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere's Disease.
Yazdani N; Nejadian F; Rezazadeh N; Hoseinabadi R; Karimi E; Gharibi R; Dabiri S
Acta Med Iran; 2018 Jan; 56(1):43-48. PubMed ID: 29436794
[TBL] [Abstract][Full Text] [Related]
22. Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.
Lambert PR; Carey J; Mikulec AA; LeBel C;
Otol Neurotol; 2016 Dec; 37(10):1669-1676. PubMed ID: 27749754
[TBL] [Abstract][Full Text] [Related]
23. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
24. Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere's disease.
Leng Y; Liu B; Zhou R; Liu J; Liu D; Zhang SL; Kong WJ
Acta Otolaryngol; 2017 Feb; 137(2):154-160. PubMed ID: 27650470
[TBL] [Abstract][Full Text] [Related]
25. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
Nedzelski JM; Chiong CM; Fradet G; Schessel DA; Bryce GE; Pfleiderer AG
Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.
Boleas-Aguirre MS; Lin FR; Della Santina CC; Minor LB; Carey JP
Otol Neurotol; 2008 Jan; 29(1):33-8. PubMed ID: 18199956
[TBL] [Abstract][Full Text] [Related]
27. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
28. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
[TBL] [Abstract][Full Text] [Related]
29. The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo.
Morita S; Nakamaru Y; Fujiwara K; Iizuka K; Masuya M; Homma A; Fukuda A; Fukuda S
Audiol Neurootol; 2016; 21(3):132-40. PubMed ID: 27077389
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome.
Harner SG; Driscoll CL; Facer GW; Beatty CW; McDonald TJ
Otol Neurotol; 2001 Mar; 22(2):210-4. PubMed ID: 11300271
[TBL] [Abstract][Full Text] [Related]
31. Intratympanic gentamicin treatment after endolymphatic sac surgery.
Gouveris H; Lange G; Mann WJ
Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
33. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
Martin E; Perez N
Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
[TBL] [Abstract][Full Text] [Related]
34. Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine.
Sbeih F; Christov F; Gluth MB
Ann Otol Rhinol Laryngol; 2018 May; 127(5):331-337. PubMed ID: 29546771
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease].
Wang QL; Guo XD; Mei XS; Li Y; Yao WJ; Yang XG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):96-99. PubMed ID: 29871195
[No Abstract] [Full Text] [Related]
36. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere's disease.
Okuda H; Aoki M; Ogawa B; Shibata H; Ueda N; Ohashi T; Hayashi H; Nishihori T; Kuze B; Ogawa T
Am J Otolaryngol; 2021; 42(6):103141. PubMed ID: 34171697
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of transtympanic dexamethasone perfusion using the MicroWick
Kim CS; Martinez U; Mulvey E; Nayak N; Silverstein H
Am J Otolaryngol; 2021; 42(5):103138. PubMed ID: 34214774
[TBL] [Abstract][Full Text] [Related]
38. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
39. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies.
Phillips J; Mikulec AA; Robinson JM; Skarinsky D; Anderson JJ
Otol Neurotol; 2023 Jul; 44(6):584-592. PubMed ID: 37185596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
